Bat Yam, Israel

Jossef Friedlander

This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jossef Friedlander. Retrieved from https://idiyas.com/inventor/jossef-friedlander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jossef Friedlander: Innovator in Human Immune Interferon Purification

Introduction

Jossef Friedlander is a notable inventor based in Bat Yam, Israel. He has made significant contributions to the field of biotechnology, particularly in the purification of biologically active human immune interferon.

Latest Patents

Friedlander holds a patent for the "Purification of biologically active human immune interferon." This innovative process allows for the purification of human immune interferon (IFN-.gamma.) to homogeneity without appreciable loss of biological activity. The method employs chromatography on controlled-pore glass, ultrafiltration, and high-performance cation exchange chromatography. The result is essentially pure human interferon subtypes 21K and 26K, along with pharmaceutical compositions containing these purified interferons.

Career Highlights

Friedlander is associated with Yeda Research and Development Co. Ltd., where he has been instrumental in advancing research in his field. His work has paved the way for new therapeutic applications of interferons, which are crucial in treating various medical conditions.

Collaborations

Friedlander has collaborated with notable colleagues, including Menachem Rubinstein and Dina G. Fischer. Their combined expertise has contributed to the success of their research initiatives.

Conclusion

Jossef Friedlander's work in the purification of human immune interferon represents a significant advancement in biotechnology. His innovative methods and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…